1. Home
  2. USAS vs NVCR Comparison

USAS vs NVCR Comparison

Compare USAS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$5.77

Market Cap

1.1B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.99

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
NVCR
Founded
1998
2000
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
USAS
NVCR
Price
$5.77
$12.99
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$4.08
$28.42
AVG Volume (30 Days)
3.5M
1.8M
Earning Date
11-10-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$104,867,000.00
$642,269,000.00
Revenue This Year
$22.65
$9.75
Revenue Next Year
$69.86
$5.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.17
52 Week Low
$0.87
$10.70
52 Week High
$5.90
$34.13

Technical Indicators

Market Signals
Indicator
USAS
NVCR
Relative Strength Index (RSI) 77.11 56.12
Support Level $4.45 $10.79
Resistance Level $4.81 $13.94
Average True Range (ATR) 0.31 0.61
MACD 0.15 0.20
Stochastic Oscillator 91.42 69.68

Price Performance

Historical Comparison
USAS
NVCR

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: